A recent article at Outsourcing Pharma with AstraZeneca finds the pharmaceutical giant mulling a future move to utilizing third party logistics providers as part of its three year study looking for ways to drive new efficiencies. AstraZeneca spokesperson Chris Dalton had this to say in a recent interview.
“Outsourcing will be part of a mixture of steps taken, including acquisitions and research collaborations, in order to enhance productivity. All options are currently being considered. We will look to fill the gaps where we no longer have the in-house capability, including using various locations across the globe.
This means we will be looking at our manufacturing supply chain to drive through efficiencies.Whether we will involve third party logistics (3PL) providers in this will depend on what opportunities arise over the next three years.”
Its always interesting seeing major corporations taking a close look at their core competencies to consider whether outsourcing can be used to drive efficiencies. It will be interesting to see what comes out of their internal study.